Related Experiment Video
Updated: Jul 15, 2026

10:40
Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Published on: December 21, 2019
Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis
L Polimeno1, A Mittelman, L Gennero
1Department of Emergency and Organ Transplantation, Gastroenterology Section, University of Bari, Bari, Italy.
Amino Acids
|April 27, 2007
Summary
This study identifies low human proteome similarity in Hepatitis C Virus (HCV) E1 epitopes, defining key immunogenic regions for potential HCV immunotherapies.
Area of Science:
- Immunology
- Virology
- Bioinformatics
Background:
- Antibody-epitope interactions are crucial for immune responses.
- Understanding viral antigenicity aids in vaccine and therapeutic development.
- Host proteome similarity can influence immune recognition of viral epitopes.
Purpose of the Study:
- To define epitopic sequences within the Hepatitis C Virus (HCV) E1 protein.
- To analyze the sequence similarity of HCV epitopes to the human proteome.
- To explore the potential of low-similarity epitopes in immunotherapeutic strategies for HCV.
Main Methods:
- Analysis of amino acid sequence similarity between viral epitopes and the human proteome.
- Identification of immunodominant linear determinants within the HCV E1(315-328) sequence.
- Characterization of immunoreactive regions based on host proteome comparison.
Main Results:
- The HCV E1(315-328) epitope exhibits low sequence similarity to human proteins.
- Two contiguous immunodominant linear determinants were identified at the termini of the HCV E1(315-328) sequence.
- Low sequence similarity to the host proteome appears to modulate viral epitopic sequences.
Conclusions:
- Low sequence similarity to the host proteome is a key factor in defining viral epitopic sequences.
- The identified immunogenic regions of the HCV E1 epitope hold potential for HCV immunotherapeutic approaches.
- This research provides a framework for designing targeted immunotherapies against viral infections like HCV.

